(NASDAQ: ANL) Adlai Nortye's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.63%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.47%.
Adlai Nortye's earnings in 2024 is -$54,065,000.On average, 2 Wall Street analysts forecast ANL's earnings for 2024 to be -$179,888,808, with the lowest ANL earnings forecast at -$262,360,908, and the highest ANL earnings forecast at -$97,416,708. On average, 1 Wall Street analyst forecast ANL's earnings for 2025 to be -$101,844,741, with the lowest ANL earnings forecast at -$101,844,741, and the highest ANL earnings forecast at -$101,844,741.
In 2026, ANL is forecast to generate -$109,593,797 in earnings, with the lowest earnings forecast at -$109,593,797 and the highest earnings forecast at -$109,593,797.